Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1

Human immunodeficiency virus type 1 (HIV-1)-infected individuals who develop drug-resistant virus during antiretroviral therapy may derive benefit from continued treatment for two reasons. First, drug-resistant viruses can retain partial susceptibility to the drug combination. Second, therapy select...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Zhang, Haili, Zhou, Yan, Alcock, Cecily, Kiefer, Tara, Monie, Daphne, Siliciano, Janet, Li, Quan, Pham, Paul, Cofrancesco, Joseph, Persaud, Deborah, Siliciano, Robert F.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2004
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC369469/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14747537/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.4.1718-1729.2004
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!